Tim Kutzkey is listed as an executive officer, director, and promoter on 3 SEC Form D filings by 2 issuers between Oct 2015 and Aug 2024: Kallyope, Inc. (New York, NY — biotechnology — 2015–2016; $28.1M reported sold to 9 investors) and NILO Therapeutics, Inc. (New York, NY — biotechnology — 2024; $9.6M reported sold to 3 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 9 years. Across those companies the filings report $37.7M sold in total.
Listed alongside Joshua Wolfe (2 shared filings), TERRY MCGUIRE (2 shared filings), TOM MANIATIS (2 shared filings), Adam Goulburn (1 shared filing), Jeff Goater (1 shared filing) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Tim. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Tim Kutzkey and found 3 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Tim Kutzkey" (CA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.